Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oskar Hansson

Showing results (1-10 of 724) with videos related to

Pageof 73
Sort By:
Nature Medicine|June 4, 2021
Biomarkers for neurodegenerative diseasesOskar Hansson
JAMA|January 23, 2025
Blood Biomarkers to Detect Alzheimer Disease-ReplySebastian Palmqvist, Oskar Hansson
Nature Medicine|December 5, 2018
Genetic characterization of amyloid-β and tau network spreadRik Ossenkoppele, Oskar Hansson
Brain : a Journal of Neurology|July 27, 2016
Brain activity and Alzheimer's disease: a complex relationshipOskar Hansson, Gunnar Gouras
Forensic Science International. Genetics|June 20, 2017
Characterisation of artefacts and drop-in events using STR-validator and single-cell analysisOskar Hansson, Peter Gill
Nature Reviews. Neurology|June 30, 2019
Primary fatty amides are potential plasma biomarkers for ADNiklas Mattsson, Oskar Hansson
Lakartidningen|May 31, 2024
[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]Kaj Blennow, Oskar Hansson
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's diseaseRik Ossenkoppele, Oskar Hansson
The Lancet. Neurology|July 24, 2021
Management of Alzheimer's disease takes a leap forwardGiovanni B Frisoni, Oskar Hansson
The Lancet. Neurology|June 16, 2016
Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?Giovanni B Frisoni, Oskar Hansson
Pageof 73

Showing results (1-10 of 724) with videos related to

Sort By:
Pageof 73
Nature Medicine|June 4, 2021
Biomarkers for neurodegenerative diseasesOskar Hansson
JAMA|January 23, 2025
Blood Biomarkers to Detect Alzheimer Disease-ReplySebastian Palmqvist, Oskar Hansson
Nature Medicine|December 5, 2018
Genetic characterization of amyloid-β and tau network spreadRik Ossenkoppele, Oskar Hansson
Brain : a Journal of Neurology|July 27, 2016
Brain activity and Alzheimer's disease: a complex relationshipOskar Hansson, Gunnar Gouras
Forensic Science International. Genetics|June 20, 2017
Characterisation of artefacts and drop-in events using STR-validator and single-cell analysisOskar Hansson, Peter Gill
Nature Reviews. Neurology|June 30, 2019
Primary fatty amides are potential plasma biomarkers for ADNiklas Mattsson, Oskar Hansson
Lakartidningen|May 31, 2024
[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]Kaj Blennow, Oskar Hansson
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2021
Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer's diseaseRik Ossenkoppele, Oskar Hansson
The Lancet. Neurology|July 24, 2021
Management of Alzheimer's disease takes a leap forwardGiovanni B Frisoni, Oskar Hansson
The Lancet. Neurology|June 16, 2016
Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?Giovanni B Frisoni, Oskar Hansson
Pageof 73